Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Remmers

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
Translational Andrology and Urology|June 12, 2023
A literature review to understand health literacy in men with prostate cancer on active surveillanceKatharina Beyer, Sebastiaan Remmers, Mieke Van Hemelrijck, et al.
World Journal of Urology|March 13, 2024
Incorporating PHI in decision making: external validation of the Rotterdam risk calculators for detection of prostate cancerLeire Rius Bilbao, Urko Aguirre Larracoechea, Carmen Valladares Gomez, et al.
BJU International|August 22, 2023
Performance of magnetic resonance imaging-based prostate cancer risk calculators and decision strategies in two large European medical centresPetter Davik, Sebastiaan Remmers, Mattijs Elschot, et al.
BJU International|May 6, 2019
Predicting biochemical recurrence and prostate cancer-specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening- and clinically detected prostate cancerSebastiaan Remmers, Jan F M Verbeek, Daan Nieboer, et al.
European Urology|November 14, 2018
Results of Prostate Cancer Screening in a Unique Cohort at 19yr of Follow-upDaniël F Osses, Sebastiaan Remmers, Fritz H Schröder, et al.
Minerva Urology and Nephrology|December 15, 2022
Sexual and urinary function in prostate cancer clinical studies and the Europa Uomo Patient Reported Outcome Study: does it match?Sebastiaan Remmers, Lionne D Venderbos, André Deschamps, et al.
BJU International|August 10, 2021
A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant?Paul Doan, Petra Graham, John Lahoud, et al.
European Urology Oncology|September 10, 2023
From Screening to Mortality Reduction: An Overview of Empirical Data on the Patient Journey in European Randomized Study of Screening for Prostate Cancer Rotterdam After 21 Years of Follow-up and a Reflection on Quality of LifeRenée Hogenhout, Sebastiaan Remmers, Marlies E van Slooten-Midderigh, et al.
European Urology Oncology|January 8, 2026
Effects of Causal and Noncausal Components of Screening on Prostate Cancer Mortality: A Mediation Analysis from the Dutch, Finnish, and Swedish Centers of the European Randomized Study of Screening for Prostate CancerSebastiaan Remmers, Kirsi Talala, Monique J Roobol, et al.
World Journal of Urology|June 25, 2021
External validation of two MRI-based risk calculators in prostate cancer diagnosisAnna-Lena Petersmann, Sebastiaan Remmers, Tilman Klein, et al.
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Translational Andrology and Urology|June 12, 2023
A literature review to understand health literacy in men with prostate cancer on active surveillanceKatharina Beyer, Sebastiaan Remmers, Mieke Van Hemelrijck, et al.
World Journal of Urology|March 13, 2024
Incorporating PHI in decision making: external validation of the Rotterdam risk calculators for detection of prostate cancerLeire Rius Bilbao, Urko Aguirre Larracoechea, Carmen Valladares Gomez, et al.
BJU International|August 22, 2023
Performance of magnetic resonance imaging-based prostate cancer risk calculators and decision strategies in two large European medical centresPetter Davik, Sebastiaan Remmers, Mattijs Elschot, et al.
BJU International|May 6, 2019
Predicting biochemical recurrence and prostate cancer-specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening- and clinically detected prostate cancerSebastiaan Remmers, Jan F M Verbeek, Daan Nieboer, et al.
European Urology|November 14, 2018
Results of Prostate Cancer Screening in a Unique Cohort at 19yr of Follow-upDaniël F Osses, Sebastiaan Remmers, Fritz H Schröder, et al.
Minerva Urology and Nephrology|December 15, 2022
Sexual and urinary function in prostate cancer clinical studies and the Europa Uomo Patient Reported Outcome Study: does it match?Sebastiaan Remmers, Lionne D Venderbos, André Deschamps, et al.
BJU International|August 10, 2021
A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant?Paul Doan, Petra Graham, John Lahoud, et al.
European Urology Oncology|September 10, 2023
From Screening to Mortality Reduction: An Overview of Empirical Data on the Patient Journey in European Randomized Study of Screening for Prostate Cancer Rotterdam After 21 Years of Follow-up and a Reflection on Quality of LifeRenée Hogenhout, Sebastiaan Remmers, Marlies E van Slooten-Midderigh, et al.
European Urology Oncology|January 8, 2026
Effects of Causal and Noncausal Components of Screening on Prostate Cancer Mortality: A Mediation Analysis from the Dutch, Finnish, and Swedish Centers of the European Randomized Study of Screening for Prostate CancerSebastiaan Remmers, Kirsi Talala, Monique J Roobol, et al.
World Journal of Urology|June 25, 2021
External validation of two MRI-based risk calculators in prostate cancer diagnosisAnna-Lena Petersmann, Sebastiaan Remmers, Tilman Klein, et al.
Pageof 10